APA

Nebbioso A., Pereira R., Khanwalkar H., Matarese F., García-Rodríguez J., Miceli M., Logie C., Kedinger V., Ferrara F., Stunnenberg H. G., de Lera A. R., Gronemeyer H. & Altucci L. (20120511). Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008. : Molecular cancer therapeutics.

Chicago

Nebbioso Angela, Pereira Raquel, Khanwalkar Harshal, Matarese Filomena, García-Rodríguez José, Miceli Marco, Logie Colin, Kedinger Valerie, Ferrara Felicetto, Stunnenberg Hendrik G, de Lera Angel R, Gronemeyer Hinrich and Altucci Lucia. 20120511. Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008. : Molecular cancer therapeutics.

Harvard

Nebbioso A., Pereira R., Khanwalkar H., Matarese F., García-Rodríguez J., Miceli M., Logie C., Kedinger V., Ferrara F., Stunnenberg H. G., de Lera A. R., Gronemeyer H. and Altucci L. (20120511). Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008. : Molecular cancer therapeutics.

MLA

Nebbioso Angela, Pereira Raquel, Khanwalkar Harshal, Matarese Filomena, García-Rodríguez José, Miceli Marco, Logie Colin, Kedinger Valerie, Ferrara Felicetto, Stunnenberg Hendrik G, de Lera Angel R, Gronemeyer Hinrich and Altucci Lucia. Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008. : Molecular cancer therapeutics. 20120511.